000			02265nam a2200433 i 4500
999			_c278823 _d278823
001			ocn682101975
003			OCoLC
005			20190213145446.0
006			m o d f
007			cr bn||||a||||
008			101117s1999 dcu ob f000 0 eng c
020			_z9780160599347
040			_aPUCPR _beng _erda _epn _cOCLCE _dOCLCQ _dOCLCF _dOCLCQ _dOCLCO _dOCLCQ _dCWCLL _dNJR _dOCLCQ _dUWO _dOCLCQ _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a1019-C-01 (online)
086	0		_aY 4.C 73/8:106-79
088			_aSerial no. 106-79 (United States. Congress. House. Committee on Commerce)
099			_aY 4.C 73/8:106-79
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Commerce. _bSubcommittee on Oversight and Investigations,
245	1	0	_aBlood safety and availability : _bhearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives ; One Hundred Sixth Congress, first session ; September 23, October 6, and October 19, 1999.
264		1	_aWashington : _bU.S. Government Printing Office, _c1999.
300			_a1 online resource (iii, 149 pages)
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"Serial no. 106-79."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588	0		_aPrint version record; online resource viewed August 1, 2016.
588			_aDescription based on online resource, PDF version; title from title page (govinfo, viewed Jan. 25, 2019).
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. _tBlood safety and availability _w(DLC) 00325617 _w(OCoLC)43533187
776	0	8	_iMicrofiche version: _aUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. _tBlood safety and availability _w(DLC) 00325617 _w(OCoLC)44441211
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo115249
650		0	_aBlood _xCollection and preservation _zUnited States _xSafety measures.
650		0	_aBlood banks _zUnited States _xSafety measures.
650		0	_aBlood banks _xInventory control _zUnited States.
942			_2sudocs _c8